Loading organizations...

§ Private Profile · Davis, CA, USA
Agtech and CPG company develops and markets plant-based health products for consumers, focused on Zola Coconut Water.
Arcadia Biosciences is a Dallas, Texas-based agricultural technology and consumer goods company that develops plant-based health and wellness products alongside proprietary crop traits. Operating as a publicly traded micro-cap entity on the NASDAQ under the ticker RKDA, the firm generated approximately $5.3 million in total revenue during the 2023 fiscal year and has raised $61.76 million in total funding. The organization has historically focused on specialty wheat ingredients with enhanced nutritional profiles, but recently streamlined its operations to prioritize the commercial growth of its Zola coconut water beverage brand. Arcadia Biosciences maintains strategic partnerships and joint ventures with recognizable industry entities, including Corteva Agriscience and Bioceres, and recently sold its GoodWheat consumer brand to Above Food Corp for $4 million. The agricultural enterprise was originally founded in 2002 by co-founders Eric Rey and John Sperling.
Arcadia Biosciences has raised $50.9M across 4 funding rounds.
Arcadia Biosciences has raised $50.9M in total across 4 funding rounds.
Arcadia Biosciences has raised $50.9M in total across 4 funding rounds.
Arcadia Biosciences's investors include Uday Garg, BASF Venture Capital, CMEA Capital, Saints Capital, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Exeter Life Sciences.
Arcadia Biosciences has raised $50.9M across 4 funding rounds. Most recently, it raised $33.0M Series D in May 2014.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 8, 2014 | $33M Series D | Uday Garg | BASF Venture Capital, CMEA Capital, Saints Capital | Announced |
| Oct 3, 2013 | $2M Grant | National Institutes OF Health | — | Announced |
| Feb 15, 2010 | $860K Grant | National Institute OF Diabetes And Digestive And Kidney Diseases | — | Announced |
| Oct 29, 2008 | $15M Venture Round | Exeter Life Sciences | BASF Venture Capital, CMEA Capital, Saints Capital | Announced |